Target intelligence / Profile preview

Immunoreceptor tyrosine-based activation motif (ITAM)

Target
ITAM
Molecular classification
Other (Sequence motif), Receptor, Adaptor protein, Non-catalytic tyrosine-phosphorylated receptor
01

Overview

The Immunoreceptor tyrosine-based activation motif (ITAM) is a sequence motif (consensus signature: YxxL/Ix_6–8_YxxL/I) repeated twice within the cytoplasmic domains of various immune receptors (e.g., CD3 chains of TCR, CD79 chains of BCR, Fc receptors, DAP12, FcRγ)[1][3][5]. Upon ligand engagement, ITAM tyrosines are phosphorylated by Src-family kinases. Phosphorylated ITAMs recruit SH2-domain proteins (notably Syk and ZAP-70 kinases), initiating intracellular signaling cascades resulting in immune cell activation, proliferation, and differentiation[1][3][5]. ITAMs are essential for adaptive immunity and are also involved in specialized functions such as osteoclast differentiation[4]. Aberrant ITAM signaling plays a role in autoimmune diseases, inflammation (e.g., rheumatoid arthritis), infection, and oncogenesis[4][6]. Therapeutic approaches typically target ITAM-associated receptors or signaling pathways, not the ITAM motif itself.

Other names
ITAMImmunoreceptor tyrosine activation motif
02

Biological functions

Signal transductionImmune responseCell activationCell proliferationOsteoclast maturation
03

Disease associations

CancerInflammation, e.g. rheumatoid arthritisInfectionAutoimmune diseaseOther (general immune-related conditions)
04

Biomarkers

OSCAR expression in rheumatoid arthritis (for ITAM-pathway activity)

Beyond the preview

Go deeper on Immunoreceptor tyrosine-based activation motif (ITAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoreceptor tyrosine-based activation motif (ITAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call